Full Press Release Details
Altimmune to Participate at Leerink Partners Therapeutics Forum.
ALT
Altimmune to Participate at Leerink Partners Therapeutics Forum
Key Takeaway: Altimmune to Participate at Leerink Partners Therapeutics Forum
Price reaction · baseline $7.2 (2024-07-01 close) · hit after-hours · 1 other ALT headline(s) in the window, move may be shared
day 0 close
-6.4%
day 1 · peak
-8.3%
day 3
-4.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight